From March 12 to 15, 2025, the 19th St. Gallen Breast Cancer Conference (SGBCC 2025) was held in Vienna, the City of Music. Leading global experts in breast cancer gathered to discuss cutting-edge advancements and hotly debated topics in breast cancer diagnosis and treatment. At the conference, Dr. Javier Cortés, Head of the International Breast Cancer Center (IBCC) in Barcelona, Spain, delivered an insightful keynote speech titled "New anti-HER2 approaches—moving up to the (neo)adjuvant setting?" Oncology Frontier invited Dr. Javier Cortés to share his perspectives and outlook on (neo)adjuvant therapy for early HER2-positive breast cancer.

Breast cancer remains the most prevalent malignancy among women and is the leading cause of cancer-related mortality, posing a significant threat to global women's health. Human epidermal growth factor receptor…

From March 12 to 15, 2025, the 19th St. Gallen Breast Cancer Conference (SGBCC 2025) was held in Vienna, the capital of music. Experts from around the world in the field of breast cancer gathered to discuss cutting-edge advancements and hotly debated topics in breast cancer diagnosis and treatment. Oncology Frontier invited Dr. Giuseppe Curigliano, the ESMO President-Elect and Associate Professor at the University of Milan and European Institute of Oncology, to share his views on the presentation topic and the outlook for curing advanced breast cancer.

Exciting news for the radiology community! Professor Valérie Vilgrain is organizing the inaugural Val d'Isère - Vilgrain Radiology Congress, set to take place from March 24-28, 2025, in the stunning…

A recent study published in the Journal of Clinical Oncology provides important insights into the prognostic role of pathogenic variants (PVs) in ATM, CHEK2, and PALB2 in breast, colorectal, and…